Dexcom (DXCM) insider trading

By person

20 insiders · 2 transactions

42.8×

Jacob Leach holds 42.8 times base salary in stock. $32.93M of shares against $768.96K in salary for 2025.

Salary from the company's own proxy. The shares are what Jacob Leach last reported holding, valued at $78.62, the price Common Stock was last bought or sold at on the open market here, on 27 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sadie Stern

EVP Chief People & Culture Off

—

$201.66K (1) scheduled

−$201.66K

120,913

0.0320%

$9.51M

+60.3%

Michael Jon Brown

EVP Chief Legal Compliance Off

—

$145.32K (1) scheduled

−$145.32K

98,185

0.0260%

$7.72M

+48.1%

Jacob Steven Leach

President, CEO, and Director

—

418,908

0.1110%

$32.93M

+57.9%

Eric Topol

Director

—

380,545

0.1008%

$29.92M

0.0%

Kevin R Sayer

Executive Chair

—

302,214

0.0801%

$23.76M

+6.5%

Jereme M Sylvain

EVP, Chief Financal Officer

—

146,828

0.0389%

$11.54M

+72.9%

Jon Coleman

EVP, Chief Commercial Officer

—

95,450

0.0253%

$7.50M

—

Nicholas Augustinos

Director

—

72,250

0.0191%

$5.68M

−6.3%

Steven R Altman

Director

—

69,232

0.0183%

$5.44M

+18.1%

Mark G Foletta

Director

—

55,183

0.0146%

$4.34M

−7.1%

Richard Alexander Collins

Director

—

45,767

0.0121%

$3.60M

+9.1%

Matthew Vincent Dolan

EVP, Strategy & Corporate Dev

—

42,044

0.0111%

$3.31M

+4.6%

Bridgette P Heller

Director

—

29,570

0.0078%

$2.32M

+21.4%

Kyle Malady

Director

—

28,242

0.0075%

$2.22M

+55.7%

Karen M Dahut

Director

—

17,779

0.0047%

$1.40M

0.0%

Rimma Driscoll

Director

—

17,319

0.0046%

$1.36M

+160.8%

Euan A. Ashley

Director

—

12,731

0.0034%

$1.00M

+432.9%

Renee D Gala

Director

—

12,486

0.0033%

$981.65K

—

Albert Frederick Osterloh IV

Director

—

8,691

0.0023%

$683.29K

—

Glenn S Boehnlein

Director

—

5,883

0.0016%

$462.52K

+13,907%

Dexcom

What the insiders did Scheduled selling only

By person